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Pulmonary Arterial Wall Distensibility
Assessed by Intravascular Ultrasound in
Children With Congenital Heart Disease*
An Indicator for Pulmonary Vascular Disease?
Rolf M. F. Berger, MD, PhD; Adri H. Cromme-Dijkhuis, MD, PhD;
Wim C. J. Hop, MSc, PhD; Marco N. Kruit; and John Hess, MD, PhD
Background: Both pulmonary hypertension and pulmonary overflow are associated with func-
tional and structural changes of the pulmonary arterial wall. Current techniques to evaluate the
pulmonary vasculature neglect the pulsatile nature of pulmonary flow.
Study objectives: To determine whether the dynamic properties of the pulmonary arterial wall are
altered in patients with abnormal pulmonary hemodynamics due to congenital heart defects, and
whether these changes are associated with the progression of pulmonary vascular disease (PVD).
Patients and methods: In 43 children with PVD due to congenital heart defects and 12 control
subjects, pulmonary arterial pulsatility (the relative increase in vessel area during the cardiac cycle)
and distensibility (the inverse of the stress/strain elastic modulus) were determined with intravascular
ultrasound. Results were correlated with clinical and hemodynamic parameters.
Results: Pulsatility correlated with pulmonary pulse pressure (p < 0.001), pulmonary-to-systemic
vascular resistance ratio (PVR/SVR) [p 0.001], and hemoglobin concentration (p 0.01). However,
when corrected for these variables, pulsatility did not differ between patients and control subjects. In
contrast, arterial wall distensibility decreased with the severity of PVD and correlated independently
with pulmonary-to-systemic arterial pressure ratio (p < 0.001) and PVR/SVR (p 0.03), and with
hemoglobin concentration (p < 0.01). Adjusted for hemodynamic variables, distensibility was still
decreased in patients with PVD compared to control subjects.
Conclusions: These results demonstrate that pulmonary arterial wall distensibility is progressively
decreased in PVD; moreover, this decreased distensibility is, in part, related to increased distending
pressure as a result of pulmonary hypertension but also, in part, to stiffening of the arterial wall
during the disease process. Arterial wall distensibility may be of additional value in the evaluation of
pulmonary vasculature and ventricular workload. (CHEST 2002; 122:549–557)
Key words: dynamics, vascular; heart defects, congenital; hypertension, pulmonary; pulmonary vascular disease; ultrasound,
intravascular
Abbreviations: CI confidence interval; EDA end-diastolic area; EDD end-diastolic dimension;
IVUS intravascular ultrasound; PAP/SAP pulmonary-to-systemic mean arterial pressure ratio; PVD pulmonary vas-
cular disease; PVR pulmonary vascular resistance; PVR/SVR pulmonary-to-systemic vascular resistance ratio;
WUWood unit
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I n children with congenital heart disease, bothpulmonary hypertension and increased pulmonary
blood flow lead to functional and structural changes
of the pulmonary vasculature from the start of their
occurrence.1–4 Progression of these vascular changes,
referred to as pulmonary vascular disease (PVD),
largely determines the management and prognosis of
these patients.1,2 Pulmonary vascular remodeling, and
thus PVD, starts from the very onset of abnormal
pulmonary hemodynamics and eventually leads to in-
creased pulmonary vascular resistance (PVR) due to
luminal narrowing in small pulmonary arteries. This
remodeling process, which includes arterial wall thick-
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ening and extracellular matrix modulation, may also
result in stiffening of the pulmonary arterial walls.5–8
The latter will cause an increase in the pulsatile load of
the right ventricle, which normally constitutes approx-
imately 30% of the total workload of the right ventri-
cle.9,10 In the clinical setting, the state of the pulmonary
vasculature is commonly evaluated at cardiac catheter-
ization by calculating PVR and its response to vasodi-
lators. Although these hemodynamic data provide valu-
able information, they are restricted to the resistance of
the pulmonary vasculature to continuous flow and,
consequently, neglect the essentials of a pulsatile cir-
culation.11,12 However, with increasing recognition of
the importance of the pulsatile component of BP in the
pathogenesis of cardiovascular diseases, this aspect of
pulmonary blood flow has become of major inter-
est.9,13,14
Intravascular ultrasound (IVUS) of the pulmonary
vasculature allows one to characterize the arterial
wall and to visualize in vivo the dynamics of elastic
pulmonary arteries. It is feasible in infants and
children and can document changes in arterial wall
properties in pulmonary hypertension.15–18 The in
vitro appearance of the elastic pulmonary arterial
wall, as determined by IVUS in patients with con-
genital heart disease and PVD, has been reported to
correlate with histopathologic grade.19 However,
real-time vascular dynamics and mechanical proper-
ties of the pulmonary arterial wall and their relation
to hemodynamic variables have not been reported
earlier in patients at different stages of PVD. The
purpose of this study was to assess pulmonary arterial
wall dynamics in children with congenital heart
disease and PVD, at very early or advanced stage,
and to compare the findings with those in children
with a normal pulmonary circulation. And, more-
over, to establish the correlation between these
findings and hemodynamic data and progression of
the vascular disease.
Materials and Methods
Patients
Patients who required diagnostic or therapeutic cardiac cath-
eterization and had increased pulmonary blood flow (pulmonary-
to-systemic blood flow ratio  1.2) and/or pulmonary hyperten-
sion (mean pulmonary artery pressure  20 mm Hg) [n 43]
were prospectively enrolled in the study, after written informed
consent of their parents. Children with normal pulmonary circu-
lation who underwent cardiac catheterization (n  12) served as
control subjects. This latter group consisted of nine patients with
left-sided obstructive lesions, normal left ventricular end-
diastolic pressure, and normal pulmonary wedge pressure who
underwent a catheter intervention, and three children with
echocardiographic suspicion of either a shunt at atrial level
(n  2) or a coronary fistula (n  1) that could not be confirmed
during cardiac catheterization. Patients with hemoglobinopa-
thies, interstitial pulmonary disease, liver or renal dysfunction,
or unstable conditions were excluded. The study was approved by
the Medical Ethical Committee of the University Hospital
Rotterdam.
Catheterization and IVUS Procedure
All procedures were performed under standardized general
anesthesia.20 Hemodynamic evaluation and IVUS imaging of the
pulmonary arteries were performed in the same procedure
according to a protocol previously reported.15 Briefly, all patients
underwent complete hemodynamic evaluation of the pulmonary
and systemic vascular beds, including vasodilator response to
inhalation of 100% oxygen, as a powerful pulmonary vasodilator.
Pulmonary blood flow was determined using the dye dilution
technique, and shunt size was determined by oximetry. Before,
during, and after the procedure, blood gas analyses were per-
formed to maintain metabolic stability. A Sonos Intravascular
Imaging System (Hewlett Packard; Andover, MA) and Sonicath
3.5F or Spy 3.0F ultrasound catheters with a 30-MHz transducer
at the tip (Boston Scientific; Watertown, MA) were used. The
ultrasound catheter was directed through a 6F sheath along the
pulmonary branch at consecutive sites in, successively, the prox-
imal, segment, and peripheral arteries identified and defined by
fluoroscopy.15,21 IVUS images were obtained and recorded on
videotape simultaneously with the ECG. IVUS imaging of the
pulmonary arteries was performed at baseline and during 100%
oxygen inhalation. The images were independently analyzed
off-line by two observers blinded for clinical and hemodynamic
data (A.H.C., R.M.F.B.). Pulmonary arterial luminal diameter
and area were measured at end-diastolic dimension (minimal)
and peak systolic dimension (maximal) [Fig 1]. The values of
three cardiac cycles were averaged for each observer, and the
mean of both averages was used for further analyses. Vascular
pulsatility was defined as the difference between planimetry
values for peak systolic area and end-diastolic area (EDA),
divided by EDA  100%.16 Arterial wall distensibility (the in-
verse of the stress/strain elastic modulus) was calculated by
dividing pulsatility by pulmonary pulse pressure (pulsatility/
systolic minus diastolic pulmonary artery pressure).14,22 Because
adequate measurement of wall dynamics was not feasible in
arteries with an end-diastolic diameter (EDD)  2.0 mm, these
arteries were excluded from pulsatility and distensibility analyses.
Patient Classification
Enrolled patients were assigned to three groups: control
subjects (group 1), children with mild-to-moderate PVD (group
2), and children with advanced PVD (group 3). Children with a
normal pulmonary circulation formed the control group. Those
with increased pulmonary blood flow and/or pulmonary hyper-
tension were defined as having mild-to-moderate PVD based on
criteria commonly used in clinical practice: PVR  4 Wood units
(WU)/m2 at baseline or a PVR responsive to 100% oxygen
inhalation (PVR at 100% oxygen inhalation  4 WU/m2 or
vasodilator response  50%). Patients were defined as having
advanced PVD if they had a baseline PVR  4 WU/m2, not
responsive to 100% oxygen (PVR at 100% oxygen inhalation
 4 WU/m2 and vasodilator response  50%). Vasodilator re-
sponse was defined as 100  (PVR baseline  PVR at 100%
oxygen inhalation)/PVR baseline.
Statistical Analysis
Interobserver agreement was determined by calculating intra-
class correlation coefficients. Pulsatility and distensibility out-
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comes, taking account of differences between and within pa-
tients, were evaluated using regression analysis for repeated
measurements using the BMDP statistical software package
(SPSS; Chicago, IL).23 Both outcomes were logarithmically trans-
formed to obtain approximate normal distributions. Univariate
comparison of IVUS data between patient groups was done using
mixed-model analysis of variance. Using backward elimination,
the clinical and hemodynamic variables most predictive for
pulsatility and distensibility were determined. To allow compar-
ison between results at baseline and at 100% oxygen inhalation,
however, regression coefficients are given for both conditions if
one of them proved to be significant. In the multivariate analysis,
we have chosen the pulmonary-to-systemic mean arterial pres-
sure ratio (PAP/SAP) and the pulmonary-to-systemic vascular
resistance ratio (PVR/SVR) to represent measures for pulmonary
arterial pressure and resistance, respectively. The limit of signif-
icance was set at p 0.05 (two sided).
Results
Clinical and Hemodynamic Data
A total of 55 patients were enrolled in the study:
31 patients with mild-to-moderate PVD, 12 patients
with advanced PVD, and 12 control subjects. Tables
1, 2 present the clinical diagnoses and patient char-
acteristics.
IVUS Data
For each patient, IVUS studies were performed in
two to seven consecutive sites along the pulmonary
arterial tree. A total of 199 artery segments were
studied, of which 196 segments had sufficient delin-
Figure 1. IVUS imaging of a segmental, elastic pulmonary artery during the cardiac cycle. Arterial
luminal area was measured at end-diastolic dimension (minimal, left) and peak systolic dimension
(maximal, right). The arrows denote the timing in the cardiac cycle.
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eation between blood and the inner vessel wall to
allow reproducible measurement of vessel dimen-
sions during the cardiac cycle. Three recordings
were excluded because of poor image quality. EDD
of the investigated vessels ranged from 1.4 to 10.4
mm; 148 of these vessels were  2 mm in diameter
and were included in wall dynamics analysis. Mea-
surements included 33 cross-sections of proximal
arteries (EDD, 6.1  2.1 mm [mean  SD]; range,
2.1 to 10.4 mm), 85 cross-sections of segment arter-
ies (mean, 3.6  1.2 mm; range, 1.8 to 7.0 mm), and
78 cross-sections of peripheral arteries (mean,
2.1  0.7 mm; range, 1.4 to 4.9 mm). The size of the
studied arteries was similar in the three patient
groups (p  0.20). There was a high level of agree-
ment between both observers. The intraclass corre-
lation coefficients for the measurement of EDD,
end-systolic dimension, EDA, and peak systolic area
were 0.997, 0.998, 0.998, and 0.998, respectively.
Vascular Pulsatility
In a univariate analysis, pulsatility at baseline corre-
lated with hemoglobin concentration (p 0.01), dia-
stolic pulmonary artery pressure (p 0.03), pulmonary
pulse pressure (p 0.08), shunt size (p 0.08), and
PVR/SVR (p 0.10) [Fig 2]. Pulmonary blood flow,
pulmonary wedge pressure, and pulmonary vasodilator
response to 100% oxygen inhalation were not corre-
lated with pulsatility. Pulsatility did not differ signifi-
cantly (p 0.29) between patients with mild-to-mod-
erate PVD (geometric mean, 23%; 95% confidence
interval [CI], 20 to 26%), patients with advanced PVD
(geometric mean, 18%; 95% CI, 14 to 24%), and
control subjects (geometric mean, 21%; 95% CI, 16 to
27%) [Fig 3, top, a]. Pulsatility at baseline and adjusted
for patient group correlated independently with pul-
monary pulse pressure and PVR/SVR and, in addition,
with hemoglobin concentration (multivariate regres-
sion, Table 3). Adjusted for these variables, no
difference in pulsatility between patient groups and
control subjects was demonstrated (p 0.58). At 100%
oxygen inhalation, pulsatility was independently corre-
lated with pulse pressure and EDA of the vessel,
without significant differences between patient groups
(Table 3).
Arterial Wall Distensibility
Arterial wall distensibility at baseline correlated
univariately with age (p 0.05), hemoglobin con-
centration (p 0.08), mean pulmonary artery pres-
sure (p  0.001), shunt size (p  0.06), PVR
(p  0.001), PAP/SAP (p 0.001), and PVR/SVR
(p  0.001) [Fig 2]. Pulmonary blood flow, pulmo-
nary wedge pressure, and pulmonary vasodilator
response to 100% oxygen inhalation were not corre-
lated with distensibility. Distensibility was decreased
(p  0.001) in patients with mild-to-moderate PVD
(geometric mean, 1.22; 95% CI, 1.04 to 1.42) com-
pared to control subjects (geometric mean, 2.15;
95% CI, 1.67 to 2.77). Wall distensibility in patients
with advanced PVD (geometric mean, 0.55; 95% CI,
0.42 to 0.71) was decreased compared to patients
with mild-to-moderate PVD and to control subjects
(both p  0.001; Fig 3, bottom, b). Distensibility was
independently associated with PAP/SAP, PVR/SVR,
Table 2—Patient Characteristics*
Characteristics Control Subjects Mild-to-Moderate PVD Advanced PVD
Patients, No. 12 31 12
Age (range), yr 5.6 (0.5–16.9) 3.7 (0.2–30.7) 2.6 (0.2–15.8)
Weight (range), kg 21.0 (8.2–51.9) 13.0 (3.0–76) 11.4 (4.3–44)
Hemodynamics
Mean PAP, mm Hg 13 3 22 9 50  12
PWP, mm Hg 8  3 9 4 11  7
Shunt size, Q˙p:Q˙s 1.0  0.0 2.6  1.5 1.2  0.4
PVR, WU/m2 1.2  0.6 1.9  1.2 10.2  3.5
*Data are presented as mean  SD unless otherwise indicated. PAP  pulmonary artery pressure; PWP  pulmonary wedge pressure;
Q˙p: Q˙s  pulmonary-to-systemic blood flow ratio.
Table 1—Diagnoses of the Study Patients
Diagnoses No.
Left-to-right shunt
Ventricular septal defect with or without
atrial septal defect or persistent
arterial duct
19
With pulmonary arterial banding 2
Atrial septal defect 6
Persistent arterial duct 2
Complete atrioventricular septal defect 1
Truncus arteriosus 1
No left-to-right shunt
Persistent pulmonary hypertension after
corrected heart defect
2
Unexplained pulmonary hypertension 1
Left-sided obstructive lesions with
pulmonary venous congestion
9
Control subjects 12
Total 55
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and hemoglobin concentration (multivariate regres-
sion; Table 4). At baseline, differences between
patient groups for distensibility (adjusted for the
described variables) just failed to reach significance
(p  0.06). At 100% oxygen inhalation, PAP/SAP
and the EDA of the vessel were identified as vari-
ables independently correlated with wall distensibil-
ity (Table 4). Adjusted for these variables, distensi-
bility at 100% oxygen inhalation differed between
the patient groups (p 0.03). Pulmonary arterial
wall distensibility in a vessel with a given EDA at a
given PAP/SAP showed a 26% decrease in patients
with mild-to-moderate PVD compared to control
subjects (p 0.012). In patients with advanced
PVD, adjusted wall distensibility showed a 39%
decrease compared to control subjects (p  0.024).
The difference in adjusted distensibility between
group 2 and group 3 (13%) was not statistically
significant (p 0.27; Fig 4).
After 100% oxygen inhalation (as pulmonary vaso-
dilator) the mean increase in EDA for all patients
combined was 2.7% (95% CI, 0.9 to 4.5; p 0.003).
There were no significant correlations between the
increase in vessel area and vessel size, patient group,
PVR/SVR, or pulmonary vasodilator response.
Discussion
In our series, pulmonary arterial wall distensibility
was progressively decreased in patients with mild-to-
moderate PVD and with advanced PVD compared to
control subjects. This in contrast to vascular pulsa-
tility, which did not differ between patient groups.
Arterial wall distensibility correlated with vascular
distending pressure (PAP/SAP). However, indepen-
dent from this latter relationship, distensibility cor-
related with PVR/SVR and hemoglobin concentra-
tion at baseline, and with vessel area at inhalation of
100% oxygen. Furthermore, after correction for
these variables, arterial wall distensibility was still
substantially decreased in patients with PVD com-
pared to control subjects. This difference was accen-
tuated by inhalation of 100% oxygen. These findings
suggest a stiffening of the pulmonary arterial wall in
PVD that can be measured in vivo with IVUS.
The structural and functional changes in the pul-
monary arteries of patients with congenital heart
disease and flow-associated pulmonary hypertension
will lead to a reduction of cross-sectional area of the
vascular bed due to luminal narrowing of the small-
est pulmonary arteries.1–4 From a morphologic point
Figure 2. Data points illustrating the correlation between vascular pulsatility (top left, A and top right,
B) or arterial wall distensibility (bottom left, C and bottom right, D) of the pulmonary arteries and
various hemodynamic parameters, in control subjects (closed circles) and patients (open circles).
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of view, the most prominent vascular changes occur
in small neomuscularized pulmonary arteries that are
not accessible for the ultrasound catheter. However,
functional and structural alterations have also been
demonstrated in the larger, elastic pulmonary arter-
ies.4,5 These alterations in tone and structure of the
wall will result in a loss of its elastic properties and
will be reflected in its dynamic behavior.3,6,7,24–26
Different types of cardiac shunts may have different
effects on pulmonary vascular dynamics, due to
different characteristics of pulmonary hemodynam-
ics. Therefore, we correlated arterial wall dynamics
primarily with pulmonary hemodynamic variables.
Vascular Pulsatility
Vascular dynamics can be described by pulsatility,
defined as the relative increase in vessel area during
Figure 3. Vascular pulsatility (top, a) and arterial wall distensibility (bottom, b) of the pulmonary
arteries at baseline and at 100% oxygen inhalation in the three patient groups. Data are expressed as
geometric means and 95% CIs. *p  0.001 compared to control subjects; **p  0.001 compared to
moderate PVD.
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the cardiac cycle. In the present study, there was no
difference in vascular pulsatility between patients
with PVD and control subjects. This might be be-
cause pulsatility is not only determined by intrinsic
properties of the wall itself, but is the net result of a
complex interaction between these intrinsic proper-
ties and “extrinsic” mechanical forces acting on the
vessel wall. Pulsatility correlated most strongly with
the pulse pressure that (acting as a direct radial
mechanical force on the arterial wall) can constitute
a major determinant of vascular pulsatility.
Arterial Wall Distensibility
The elastic properties of a vessel wall can be
characterized in vivo by arterial distensibility, the
inverse of the stress/strain elastic modulus. Arterial
distensibility reflects the relative increase in arterial
area (strain) per millimeters of mercury increase in
arterial BP (ie, pulse pressure [stress]), and repre-
sents a measure for arterial compliance.14,22,26 A
decreased distensibility of the systemic arteries has
been demonstrated in essential hypertension, coro-
nary artery disease, diabetes mellitus, and aging.14
However, because the arterial wall exhibits a nonlin-
ear, viscoelastic behavior, distensibility is directly
affected by the distending pressure. Under these
conditions, it remains debatable whether the de-
crease in distensibility is a consequence of elevated
distending pressure and, thus, of the artery operating
on a steeper part of its pressure-volume relationship,
or is a result of changes in the vessel wall itself.14 We
found that pulmonary arterial wall distensibility de-
creased progressively with the severity of PVD, and
that the decreased distensibility correlated strongly
with an increase in PAP/SAP, reflecting an elevated
distending pressure. However, independent from
this distending pressure, at baseline distensibility
correlated with PVR/SVR.
These findings indicate that pulsatility and disten-
sibility of elastic pulmonary arteries correlate with
changes at the level of the pulmonary vascular bed,
reflected by PVR/SVR. Moreover, this correlation
proved to be independent from a concomitant rise in
pulmonary artery pressure. Hemoglobin concentra-
tion (regarded as a measure for blood viscosity) will
affect inertia, pulse wave propagation, and shear
stress on the arterial wall and, consequently, may
directly influence vascular dynamics.9,27
How can the effects of oxygen inhalation on these
relations be explained? Inhaled oxygen is a powerful
pulmonary vasodilator. In the pulmonary circulation,
the effect of selective vasodilation is most prominent
in the small muscular arteries of the vascular bed,
causing a decrease in PVR.11 In the present study,
oxygen did not affect the distensibility of the larger
pulmonary arteries, suggesting that muscular tone is
not an important contributing factor in the distensi-
bility of these elastic arteries. This agrees with data
Table 4—Multivariate Analysis of Distensibility at Baseline and at 100% Oxygen Inhalation*
Variables
Distensibility at Baseline Distensibility at 100% Oxygen
Data Change, % p Value Data Change, % p Value
PAP/SAP  0.06  0.01  13  0.001  0.05  0.01  11  0.001
PVR/SVR  0.04  0.02  9 0.03  0.004  0.011  1 0.71
Hemoglobin  0.05  0.02  11 0.008  0.007  0.018  2 0.70
EDA 0.001  0.001  0.2 0.22 0.003  0.001  0.7 0.02
*Data given are regression coefficients with 10log distensibility as dependent variable. See Table 3 for definitions. Differences between patient
groups for distensibility, adjusted for the described variables, just failed to reach statistical significance at baseline (p  0.06). Distensibility at
oxygen inhalation, adjusted for the described variables, differed between patient groups (p 0.03).
Table 3—Multivariate Analysis of Pulsatility at Baseline and at 100% Oxygen Inhalation*
Variables
Pulsatility at Baseline Pulsatility at 100% Oxygen
Data Change, % p Value Data Change, % p Value
Pulse pressure 0.010  0.003  2  0.001 0.009  0.002  2  0.001
PVR/SVR  0.05  0.02  11 0.001  0.01  0.01  2 0.20
Hemoglobin  0.05  0.02  11 0.01  0.02  0.02  4 0.41
EDA 0.001  0.001  0.2 0.30 0.003  0.001  0.7 0.01
*Data given are regression coefficients with 10log pulsatility as dependent variable. Change indicates the percentage change in pulsatility per
millimeters of mercury change in pulse pressure, per 0.1-U change in PVR/SVR, per millimole per liter change in hemoglobin concentration,
and per millimeters squared change in EDA. Data given are adjusted for patient group. Adjusted for the described variables, no differences
between patient groups could be demonstrated for pulsatility (at baseline, p 0.58; at oxygen inhalation, p 0.23).
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from the rat lung that suggest that decreased disten-
sibility in monocrotaline-induced pulmonary hyper-
tension is due to structural changes in the vascular
wall rather than to increased muscular tonus.28,29
Thus, the independent correlation of pulsatility and
distensibility with PVR/SVR disappears during selec-
tive pulmonary vasodilation because of the different
vasodilator response of muscular and elastic pulmo-
nary arteries. The effect of viscosity on vascular
dynamics depends on the area of the vessel27; in our
study, the increased EDA found on IVUS after
inhalation of 100% oxygen may have diminished, or
eliminated, the measurable effect of hemoglobin on
vascular wall dynamics. The extent of this increase in
vessel diameter did not correlate with vessel size,
PVR/SVR, pulmonary vasodilator response, or pa-
tient group. This means that determination of pul-
monary artery dilatation with IVUS is not inter-
changeable with the assessment of vasodilator
response as currently practiced by assessing the
response of PVR.30,31
An important finding of our study is that, after
correction for all the described variables, pulmonary
arterial wall distensibility was still decreased in pa-
tients with PVD compared to control subjects. After
adjustment for hemodynamic variables, vessel size,
and hemoglobin concentration, a mean decrease in
arterial wall distensibility of approximately 40% was
seen in patients with advanced PVD. In our opinion,
this decrease indicates a stiffening of the pulmonary
arterial wall caused by intrinsic properties of the
arterial wall, which cannot be assessed with hemo-
dynamic variables. Arterial wall stiffness is consid-
ered to be important in both the pathogenesis and
clinical course of PVD.9,14 Pulmonary arterial wall
distensibility is a new feature in the assessment of
the pulmonary vasculature, which is easily obtained
during routine cardiac catheterization. It may pro-
vide additional information on PVD and its effect on
right ventricular load. Moreover, this parameter may
be useful when evaluating and interpreting the ef-
fects of therapies for advanced PVD, such as high-
dose calcium-channel blocking therapy or continu-
ous infusion of epoprostenol.
Study Limitations
The definitions of mild-to-moderate and advanced
PVD (based on hemodynamic parameters) used in
our study are subjective, but are commonly used in
clinical practice. Because the design of this in vivo
study did not allow comparison with corresponding
histologic sections of the arteries studied with IVUS,
Figure 4. Relation between pulmonary arterial wall distensibility at 100% oxygen inhalation (adjusted
for an EDA of 15 mm2) and the PAP/SAP. The solid regression line represents the relation in control
subjects (open circles), the dotted regression line represents the relation in patients with mild-to-
moderate PVD (closed circles), and the dashed regression line represents the relation in patients with
advanced PVD (triangles).
556 Clincial Investigations
 at Swets Subscription Service on November 15, 2006 www.chestjournal.orgDownloaded from 
decreased arterial wall distensibility could not be
directly related with structural changes of the arterial
wall.
In conclusion, we have demonstrated that pulmo-
nary arterial wall distensibility is progressively de-
creased in PVD. Our data suggest that this decrease is,
in part, related to an increased distending pressure as a
result of pulmonary hypertension and, in part, to a
stiffening of the arterial wall in the disease process.
These changes in wall properties of elastic pulmonary
arteries correlated with changes at the level of the
pulmonary vascular bed. Moreover, this correlation was
independent from a rise in pulmonary artery pressure.
Pulmonary arterial wall distensibility may become a
new variable in the in vivo evaluation of the pulmonary
vasculature. This variable takes into account the pulsa-
tile nature of the pulmonary circulation and thereby
provides additional information on the progression of
pulmonary vascular disease and its consequences for
the integrated pulmonary circulation and right ventric-
ular load.
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